Einat B. Vitner

2.7k total citations
29 papers, 1.3k citations indexed

About

Einat B. Vitner is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Einat B. Vitner has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Cell Biology. Recurrent topics in Einat B. Vitner's work include Lysosomal Storage Disorders Research (16 papers), Cellular transport and secretion (11 papers) and Calcium signaling and nucleotide metabolism (7 papers). Einat B. Vitner is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Cellular transport and secretion (11 papers) and Calcium signaling and nucleotide metabolism (7 papers). Einat B. Vitner collaborates with scholars based in Israel, United States and United Kingdom. Einat B. Vitner's co-authors include Anthony H. Futerman, Tamar Farfel‐Becker, Frances M. Platt, Raya Eilam, Inbal Biton, Anna Meshcheriakova, Andrés D. Klein, Timothy M. Cox, Alfred H. Merrill and Stefan Karlsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Einat B. Vitner

29 papers receiving 1.3k citations

Peers

Einat B. Vitner
Gustavo Maegawa United States
Einat B. Vitner
Citations per year, relative to Einat B. Vitner Einat B. Vitner (= 1×) peers Gustavo Maegawa

Countries citing papers authored by Einat B. Vitner

Since Specialization
Citations

This map shows the geographic impact of Einat B. Vitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einat B. Vitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einat B. Vitner more than expected).

Fields of papers citing papers by Einat B. Vitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einat B. Vitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einat B. Vitner. The network helps show where Einat B. Vitner may publish in the future.

Co-authorship network of co-authors of Einat B. Vitner

This figure shows the co-authorship network connecting the top 25 collaborators of Einat B. Vitner. A scholar is included among the top collaborators of Einat B. Vitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einat B. Vitner. Einat B. Vitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lou, Junzhe, Einat B. Vitner, Kwasi Adu‐Berchie, et al.. (2024). Surface‐Functionalized Microgels as Artificial Antigen‐Presenting Cells to Regulate Expansion of T Cells. Advanced Materials. 36(31). e2309860–e2309860. 11 indexed citations
2.
Sobral, Miguel C., Ryan S. Lane, Einat B. Vitner, et al.. (2024). IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines. Proceedings of the National Academy of Sciences. 121(48). e2322356121–e2322356121. 1 indexed citations
3.
Avraham, Roy, Hagit Achdout, Noam Erez, et al.. (2023). Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system. Brain Communications. 5(3). fcad086–fcad086. 6 indexed citations
4.
Mechaly, Adva, Einat B. Vitner, Yinon Levy, et al.. (2021). Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection. Pathogens. 10(3). 285–285. 3 indexed citations
5.
Vitner, Einat B., Hagit Achdout, Roy Avraham, et al.. (2021). Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. Journal of Biological Chemistry. 296. 100470–100470. 29 indexed citations
6.
Achdout, Hagit, Einat B. Vitner, Boaz Politi, et al.. (2021). Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nature Communications. 12(1). 5819–5819. 50 indexed citations
7.
Achdout, Hagit, Orit Berhani, Einat B. Vitner, et al.. (2021). SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. PLoS Pathogens. 17(12). e1010175–e1010175. 17 indexed citations
8.
Vitner, Einat B., Roy Avraham, Boaz Politi, Sharon Melamed, & Tomer Israely. (2021). Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology. Life Science Alliance. 5(1). e202101168–e202101168. 24 indexed citations
9.
Melamed, Sharon, Roy Avraham, Noam Erez, et al.. (2020). Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis. Acta Neuropathologica Communications. 8(1). 144–144. 9 indexed citations
10.
Vardi, Ayelet, Einat B. Vitner, Hye Jung Park, et al.. (2020). Substrate reduction therapy using Genz‐667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease. Journal of Neurochemistry. 156(5). 692–701. 17 indexed citations
11.
Sittner, Assa, Adva Mechaly, Einat B. Vitner, et al.. (2018). Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection. Journal of Biological Methods. 5(4). 1–1. 6 indexed citations
12.
Vitner, Einat B., Tamar Farfel‐Becker, Dena Leshkowitz, et al.. (2016). Induction of the type I interferon response in neurological forms of Gaucher disease. Journal of Neuroinflammation. 13(1). 104–104. 53 indexed citations
13.
Vitner, Einat B., Ran Salomon, Tamar Farfel‐Becker, et al.. (2014). RIPK3 as a potential therapeutic target for Gaucher's disease. Nature Medicine. 20(2). 204–208. 130 indexed citations
14.
Farfel‐Becker, Tamar, Einat B. Vitner, Steven L. Kelly, et al.. (2013). Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Human Molecular Genetics. 23(4). 843–854. 117 indexed citations
15.
Vitner, Einat B. & Anthony H. Futerman. (2013). Neuronal Forms of Gaucher Disease. Handbook of experimental pharmacology. 405–419. 35 indexed citations
16.
Vitner, Einat B., Tamar Farfel‐Becker, Raya Eilam, Inbal Biton, & Anthony H. Futerman. (2012). Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Brain. 135(6). 1724–1735. 119 indexed citations
17.
Farfel‐Becker, Tamar, et al.. (2011). Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Human Molecular Genetics. 20(7). 1375–1386. 84 indexed citations
18.
Vitner, Einat B., Frances M. Platt, & Anthony H. Futerman. (2010). Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases. Journal of Biological Chemistry. 285(27). 20423–20427. 279 indexed citations
19.
Vitner, Einat B., Hila Zigdon, Tamar Farfel‐Becker, et al.. (2010). Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Human Molecular Genetics. 19(18). 3583–3590. 68 indexed citations
20.
Farfel‐Becker, Tamar, et al.. (2009). No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Human Molecular Genetics. 18(8). 1482–1488. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026